Aug 082016
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MD – REGENXBIO Inc. (NASDAQ:RGNX), a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus gene therapy based on its proprietary NAV Technology Platform, today announced the appointment of Daniel J.… => Read more

REGENXBIO appointed Dan Abdun-Nabi to its Board of Directors

From:: REGENXBIO appointed Dan Abdun-Nabi to its Board of Directors

 Posted by at 9:01 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: